151 related articles for article (PubMed ID: 37729521)
1. Nanoscale Metal-Organic Frameworks Combined with Metal Nanoparticles and Metal Oxide/Peroxide to Relieve Tumor Hypoxia for Enhanced Photodynamic Therapy.
Shi P; Sun X; Yuan H; Chen K; Bi S; Zhang S
ACS Biomater Sci Eng; 2023 Oct; 9(10):5441-5456. PubMed ID: 37729521
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
3. Engineering nanoenzymes integrating Iron-based metal organic frameworks with Pt nanoparticles for enhanced Photodynamic-Ferroptosis therapy.
Ye Y; Yu H; Chen B; Zhao Y; Lv B; Xue G; Sun Y; Cao J
J Colloid Interface Sci; 2023 Sep; 645():882-894. PubMed ID: 37178565
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-Triggered Nanoscale Metal-Organic Frameworks for Enhanced Anticancer Activity.
Liu M; Wang L; Zheng X; Liu S; Xie Z
ACS Appl Mater Interfaces; 2018 Jul; 10(29):24638-24647. PubMed ID: 29957930
[TBL] [Abstract][Full Text] [Related]
5. Biomimetic Platinum Nanozyme Immobilized on 2D Metal-Organic Frameworks for Mitochondrion-Targeting and Oxygen Self-Supply Photodynamic Therapy.
Gao Z; Li Y; Zhang Y; Cheng K; An P; Chen F; Chen J; You C; Zhu Q; Sun B
ACS Appl Mater Interfaces; 2020 Jan; 12(2):1963-1972. PubMed ID: 31873002
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoscale metal organic framework-based nanoplatforms in photodynamic therapy and further applications.
Gao D; Gao Y; Shen J; Wang Q
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102026. PubMed ID: 32979544
[TBL] [Abstract][Full Text] [Related]
7. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy.
Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G
Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704
[TBL] [Abstract][Full Text] [Related]
9. A MnO
Zhu D; Wang B; Zhu XH; Zhu HL; Ren SZ
Nanomedicine; 2021 Oct; 37():102440. PubMed ID: 34256062
[TBL] [Abstract][Full Text] [Related]
10. A Mesoporous Nanoenzyme Derived from Metal-Organic Frameworks with Endogenous Oxygen Generation to Alleviate Tumor Hypoxia for Significantly Enhanced Photodynamic Therapy.
Wang D; Wu H; Lim WQ; Phua SZF; Xu P; Chen Q; Guo Z; Zhao Y
Adv Mater; 2019 Jul; 31(27):e1901893. PubMed ID: 31095804
[TBL] [Abstract][Full Text] [Related]
11. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor.
Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J
ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181
[TBL] [Abstract][Full Text] [Related]
13. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
14. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development.
Sun Y; Zhao D; Wang G; Wang Y; Cao L; Sun J; Jiang Q; He Z
Acta Pharm Sin B; 2020 Aug; 10(8):1382-1396. PubMed ID: 32963938
[TBL] [Abstract][Full Text] [Related]
15. Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
He Z; Dai Y; Li X; Guo D; Liu Y; Huang X; Jiang J; Wang S; Zhu G; Zhang F; Lin L; Zhu JJ; Yu G; Chen X
Small; 2019 Jan; 15(4):e1804131. PubMed ID: 30565431
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends.
Shih CY; Wang PT; Su WC; Teng H; Huang WL
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535466
[TBL] [Abstract][Full Text] [Related]
17. Metal-Organic Frameworks@Au Nanoreactor as an Oxidative Stress Amplifier for Enhanced Tumor Photodynamic Therapy through the Alleviation of Hypoxemia and the Depletion of Glutathione.
Wang H; Chen T; Ren H; Liu W; Nan F; Ge J; Wang P
ACS Appl Bio Mater; 2023 Sep; 6(9):3376-3386. PubMed ID: 36912885
[TBL] [Abstract][Full Text] [Related]
18. Metal-Organic Framework PCN-224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy.
Yuan H; Chen K; Geng J; Wu Z; Wang C; Shi P
Chemistry; 2024 Apr; ():e202400319. PubMed ID: 38606488
[TBL] [Abstract][Full Text] [Related]
19. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy.
Ni K; Lan G; Lin W
ACS Cent Sci; 2020 Jun; 6(6):861-868. PubMed ID: 32607433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
